Novo Nordisk

Novo Nordisk applies Amazon Bedrock to drug discovery and clinical documentation

Novo Nordisk · Drug discovery · AWS

Novo Nordisk has deployed AWS technology across internal AI workloads and is expanding AI into drug discovery and research operations through a strategic partnership with AWS. More than 25,000 employees use a generative-AI platform built on Amazon Bedrock, while a Bedrock-based system supports clinical-study documentation with medical review.

Novo Nordisk Uses ML for Computer Vision to Optimize Pharmaceutical Manufacturing on AWS

Novo Nordisk · Industrial inspection · AWS

Novo Nordisk A/S uses computer vision and machine learning on AWS to automate manufacturing quality tasks such as cartridge counting and anomaly detection for agar plates. The company built a prototyping solution to train, deploy, monitor, and manage ML models for edge devices and to support regulated pharmaceutical operations.

Production

Novo Nordisk Scales to 2,500+ Use Cases with Secure Generative AI Using Amazon Bedrock

Novo Nordisk · AI platform · AWS

Novo Nordisk, a multinational pharmaceutical company based in Denmark, wanted to democratize employee innovation by enabling secure and compliant use of generative AI in nonregulated processes. They developed a self-service generative AI platform on AWS using Amazon Bedrock, DynamoDB, and AWS Lambda, enabling employees to build, customize, and share chatbots. The solution reduced innovation cycle time from months to days and lowered operational costs, resulting in over 25,000 employees creating chatbots for more than 2,500 use cases across various workflows.

Scaled Production

Novo Nordisk transforms drug development with AI integration

Novo Nordisk · Precision medicine · Microsoft

Novo Nordisk, a global pharmaceutical leader, is revolutionizing drug development through strategic integration of AI and advanced analytics. Spearheaded by Dr. Faisal M. Khan, the company's corporate vice president of AI and analytics, Novo Nordisk leverages partnerships with Valo Health, Microsoft, MIT, and NVIDIA. They invest heavily in AI talent, infrastructure, and the establishment of innovation hubs such as the national AI Innovation Centre in Denmark and a new AI research hub in London. Key AI applications include accelerating the identification of drug candidates for chronic diseases and designing personalized treatment plans to improve patient outcomes. Infrastructure improvements include leveraging Microsoft's cloud technology for scaled computational power and NVIDIA hardware for supercomputing. Challenges include managing vast data, navigating complex regulations, and attracting top AI talent. The company remains committed to advancing global collaborations and ensuring sustainable, renewable-powered data center operations for long-term pharmaceutical innovation.

Novo Nordisk Advances Drug Discovery Using Microsoft AI

Novo Nordisk · Drug discovery · Microsoft

Novo Nordisk established a platform-based collaboration with Microsoft to incorporate Azure AI and computational services into its drug-discovery processes. This partnership aims to improve efficiency in identifying patterns in clinical data, forecasting disease risks, and summarizing scientific literature. Operating in a multi-year framework, these AI models also assist in disease biomarker validation and aligning foundational health models with patient-care results.